IDEAS home Printed from https://ideas.repec.org/d/dsibuus.html
 

Publications

by members of

Department of Strategy and Innovation
Questrom School of Business
Boston University
Boston, Massachusetts (United States)

These are publications listed in RePEc written by members of the above institution who are registered with the RePEc Author Service. Thus this compiles the works all those currently affiliated with this institution, not those affilated at the time of publication. List of registered members. Register yourself. Citation analysis. This page is updated in the first days of each month.
| Working papers | Journal articles | Chapters |

Working papers

Undated material is listed at the end

2023

  1. Pyung Nahm & Raviv Murciano-Goroff & Michael Park & Russell J. Funk, 2023. "Serendipity in Science," Papers 2308.07519, arXiv.org.

2021

  1. Raviv Murciano-Goroff & Ran Zhuo & Shane Greenstein, 2021. "Hidden Software and Veiled Value Creation: Illustrations from Server Software Usage," NBER Working Papers 28738, National Bureau of Economic Research, Inc.
  2. Liran Einav & Peter J. Klenow & Jonathan D. Levin & Raviv Murciano-Goroff, 2021. "Customers and Retail Growth," NBER Working Papers 29561, National Bureau of Economic Research, Inc.

2019

  1. Funk, Russell J. & Glennon, Britta & Lane, Julia & Murciano-Goroff, Raviv & Ross, Matthew B., 2019. "Money for Something: Braided Funding and the Structure and Output of Research Groups," IZA Discussion Papers 12762, Institute of Labor Economics (IZA).

2018

  1. Iain M. Cockburn & Rebecca Henderson & Scott Stern, 2018. "The Impact of Artificial Intelligence on Innovation," NBER Working Papers 24449, National Bureau of Economic Research, Inc.

2015

  1. Freeman, Richard Barry & Ganguli, Ina & Murciano-Goroff, Raviv, 2015. "Why and Wherefore of Increased Scientific Collaboration," Scholarly Articles 34305979, Harvard University Department of Economics.

2014

  1. Iain Cockburn & Jean O. Lanjouw & Mark Schankerman, 2014. "Patents and the Global Diffusion of New Drugs," CEP Discussion Papers dp1298, Centre for Economic Performance, LSE.

2013

  1. Cockburn, Iain M & Agrawal, Ajay & Galasso, Alberto & Oettl, Alexander, 2013. "Why are some regions more innovative than others? The role of firm size diversity," CEPR Discussion Papers 9766, C.E.P.R. Discussion Papers.
  2. Ernst R. Berndt & Iain M. Cockburn, 2013. "Price Indexes for Clinical Trial Research: A Feasibility Study," NBER Working Papers 18918, National Bureau of Economic Research, Inc.
  3. Murray L. Aitken & Ernst R. Berndt & Barry Bosworth & Iain M. Cockburn & Richard Frank & Michael Kleinrock & Bradley T. Shapiro, 2013. "The Regulation of Prescription Drug Competition and Market Responses: Patterns in Prices and Sales Following Loss of Exclusivity," NBER Working Papers 19487, National Bureau of Economic Research, Inc.
  4. Ajay Agrawal & Iain Cockburn & Laurina Zhang, 2013. "Deals Not Done: Sources of Failure in the Market for Ideas," NBER Working Papers 19679, National Bureau of Economic Research, Inc.

2009

  1. Ajay K. Agrawal & Iain M. Cockburn & Carlos Rosell, 2009. "Not Invented Here? Innovation in Company Towns," NBER Working Papers 15437, National Bureau of Economic Research, Inc.
  2. Cockburn, Iain M. & MacGarvie, Megan J. & Müller, Elisabeth, 2009. "Patent thickets, licensing and innovative performance," ZEW Discussion Papers 08-101 [rev.], ZEW - Leibniz Centre for European Economic Research.

2007

  1. Iain M. Cockburn & Stefan Wagner, 2007. "Patents and the Survival of Internet-related IPOs," NBER Working Papers 13146, National Bureau of Economic Research, Inc.
  2. Iain M. Cockburn & Megan MacGarvie, 2007. "Patents, Thickets, and the Financing of Early-Stage Firms: Evidence from the Software Industry," NBER Working Papers 13644, National Bureau of Economic Research, Inc.

2006

  1. Jeffrey L. Furman & Margaret K. Kyle & Iain M. Cockburn & Rebecca Henderson, 2006. "Public & Private Spillovers, Location and the Productivity of Pharmaceutical Research," NBER Working Papers 12509, National Bureau of Economic Research, Inc.
  2. Iain M. Cockburn & Megan J. MacGarvie, 2006. "Entry and Patenting in the Software Industry," NBER Working Papers 12563, National Bureau of Economic Research, Inc.

2004

  1. Paul D. Chwelos & Ernst R. Berndt & Iain M. Cockburn, 2004. "Faster, Smaller, Cheaper: An Hedonic Price Analysis of PDAs," NBER Working Papers 10746, National Bureau of Economic Research, Inc.

2003

  1. Ajay Agrawal & Iain Cockburn & John McHale, 2003. "Gone But Not Forgotten: Labor Flows, Knowledge Spillovers, and Enduring Social Capital," NBER Working Papers 9950, National Bureau of Economic Research, Inc.

2002

  1. Iain M. Cockburn & Samuel Kortum & Scott Stern, 2002. "Are All Patent Examiners Equal? The Impact of Examiner Characteristics," NBER Working Papers 8980, National Bureau of Economic Research, Inc.
  2. Ajay Agrawal & Iain M. Cockburn, 2002. "University Research, Industrial R&D, and the Anchor Tenant Hypothesis," NBER Working Papers 9212, National Bureau of Economic Research, Inc.

2000

  1. Jean O. Lanjouw & Iain Cockburn, 2000. "Do Patents Matter?: Empirical Evidence after GATT," NBER Working Papers 7495, National Bureau of Economic Research, Inc.

1999

  1. Iain Cockburn & Rebecca Henderson & Scott Stern, 1999. "Balancing Incentives: The Tension Between Basic and Applied Research," NBER Working Papers 6882, National Bureau of Economic Research, Inc.
  2. Iain Cockburn & Rebecca Henderson & Scott Stern, 1999. "The Diffusion of Science-Driven Drug Discovery: Organizational Change in Pharmaceutical Research," NBER Working Papers 7359, National Bureau of Economic Research, Inc.

1998

  1. Iain M. Cockburn & Aslam H. Anis, 1998. "Hedonic Analysis of Arthritis Drugs," NBER Working Papers 6574, National Bureau of Economic Research, Inc.

1997

  1. Iain Cockburn & Rebecca Henderson, 1997. "Public-Private Interaction and the Productivity of Pharmaceutical Research," NBER Working Papers 6018, National Bureau of Economic Research, Inc.
  2. Ernst R. Berndt & Iain M. Cockburn & Douglas L. Cocks & Arnold Epstein & Zvi Griliches, 1997. "Is Price Inflation Different for the Elderly? An Empirical Analysis of Prescription Drugs," NBER Working Papers 6182, National Bureau of Economic Research, Inc.

1996

  1. Ellison, S & Cockburn, I & Griliches, A & Hausman, J, 1996. "Characteristics of Demand for Pharmaceutical Products : an Examination of four Cephalosporins," Working papers 96-24, Massachusetts Institute of Technology (MIT), Department of Economics.

1994

  1. Cockburn, Iain. & Henderson, Iain., 1994. "Racing to invest? : the dynamics of competition in ethical drug discovery," Working papers 3710-94., Massachusetts Institute of Technology (MIT), Sloan School of Management.
  2. Henderson, Rebecca. & Cockburn, Iain., 1994. "Measuring competence? : exploring firm effects in pharmaceutical research," Working papers 3712-94., Massachusetts Institute of Technology (MIT), Sloan School of Management.

1993

  1. Henderson, Rebecca. & Cockburn, Iain., 1993. "Scale, scope and spillovers : the determinants of research productivity in ethical drug discovery," Working papers 3629-93., Massachusetts Institute of Technology (MIT), Sloan School of Management.
  2. Henderson, Rebecca. & Cockburn, Iain., 1993. "Racing or spilling? : the determinants of research productivity in ethical drug discovery," Working papers 3642-93., Massachusetts Institute of Technology (MIT), Sloan School of Management.
  3. Zvi Griliches & Iain Cockburn, 1993. "Generics and New Goods in Pharmaceutical Price Indexes," NBER Working Papers 4272, National Bureau of Economic Research, Inc.
  4. Rebecca Henderson & Iain Cockburn, 1993. "Scale, Scope and Spillovers: The Determinants of Research Productivity in the Pharmaceutical Industry," NBER Working Papers 4466, National Bureau of Economic Research, Inc.

1992

  1. Iain Cockburn & Murray Frank, 1992. "Market Conditions and Retirement of Physical Capital: Evidence fron Oil Tankers," NBER Working Papers 4194, National Bureau of Economic Research, Inc.

1987

  1. Iain Cockburn & Zvi Griliches, 1987. "Industry Effects and Appropriability Measures in the Stock Markets Valuation of R&D and Patents," NBER Working Papers 2465, National Bureau of Economic Research, Inc.

Undated

  1. Peiming Wang & Iain Cockburn & Martin L. Puterman, "undated". "A Mixed Poisson Regression Model for Analysis of Patent Data," Computing in Economics and Finance 1996 _049, Society for Computational Economics.
  2. Rebecca Henderson & Iain Cockburn, "undated". "Scale, Scope and Spillovers: The Determinants of Research Productivity in Drug Discovery," Working Papers ec25/94, Department of Economics, University of Lancaster.

Journal articles

2023

  1. Iain Cockburn & Megan MacGarvie & John McKeon, 2023. "Canada’s Patent Productivity Paradox: Recent Trends and Implications for Future Productivity Growth," International Productivity Monitor, Centre for the Study of Living Standards, vol. 45, pages 120-154, Fall.
  2. Matthew B. Ross & Britta M. Glennon & Raviv Murciano-Goroff & Enrico G. Berkes & Bruce A. Weinberg & Julia I. Lane, 2023. "Author Correction: Women are credited less in science than men," Nature, Nature, vol. 621(7979), pages 41-41, September.

2022

  1. Raviv Murciano-Goroff, 2022. "Missing Women in Tech: The Labor Market for Highly Skilled Software Engineers," Management Science, INFORMS, vol. 68(5), pages 3262-3281, May.
  2. Matthew B. Ross & Britta M. Glennon & Raviv Murciano-Goroff & Enrico G. Berkes & Bruce A. Weinberg & Julia I. Lane, 2022. "Women are credited less in science than men," Nature, Nature, vol. 608(7921), pages 135-145, August.

2021

  1. Murciano-Goroff, Raviv & Zhuo, Ran & Greenstein, Shane, 2021. "Hidden software and veiled value creation: Illustrations from server software usage," Research Policy, Elsevier, vol. 50(9).

2016

  1. Iain M. Cockburn & Jean O. Lanjouw & Mark Schankerman, 2016. "Patents and the Global Diffusion of New Drugs," American Economic Review, American Economic Association, vol. 106(1), pages 136-164, January.

2015

  1. Ajay Agrawal & Iain Cockburn & Laurina Zhang, 2015. "Deals not done: Sources of failure in the market for ideas," Strategic Management Journal, Wiley Blackwell, vol. 36(7), pages 976-986, July.
  2. Leonard P Freedman & Iain M Cockburn & Timothy S Simcoe, 2015. "The Economics of Reproducibility in Preclinical Research," PLOS Biology, Public Library of Science, vol. 13(6), pages 1-9, June.

2014

  1. Agrawal, Ajay & Cockburn, Iain & Galasso, Alberto & Oettl, Alexander, 2014. "Why are some regions more innovative than others? The role of small firms in the presence of large labs," Journal of Urban Economics, Elsevier, vol. 81(C), pages 149-165.

2013

  1. Mueller, Elisabeth & Cockburn, Iain M. & MacGarvie, Megan, 2013. "Access to intellectual property for innovation: Evidence on problems and coping strategies from German firms," Research Policy, Elsevier, vol. 42(2), pages 529-541.

2012

  1. Landon Kleis & Paul Chwelos & Ronald V. Ramirez & Iain Cockburn, 2012. "Information Technology and Intangible Output: The Impact of IT Investment on Innovation Productivity," Information Systems Research, INFORMS, vol. 23(1), pages 42-59, March.

2011

  1. Iain M. Cockburn & Megan J. MacGarvie, 2011. "Entry and Patenting in the Software Industry," Management Science, INFORMS, vol. 57(5), pages 915-933, May.
  2. Ernst Berndt & Nathan Blalock & Iain Cockburn, 2011. "Diffusion of New Drugs in the Post-TRIPS Era," International Journal of the Economics of Business, Taylor & Francis Journals, vol. 18(2), pages 203-224.

2010

  1. Cockburn Iain M. & Stern Scott, 2010. "Finding the Endless Frontier: Lessons from the Life Sciences Innovation System for Technology Policy," Capitalism and Society, De Gruyter, vol. 5(1), pages 1-50, July.
  2. Agrawal, Ajay & Cockburn, Iain & Rosell, Carlos, 2010. "Not Invented Here? Innovation in company towns," Journal of Urban Economics, Elsevier, vol. 67(1), pages 78-89, January.
  3. Wagner, S. & Cockburn, I., 2010. "Patents and the survival of Internet-related IPOs," Research Policy, Elsevier, vol. 39(2), pages 214-228, March.
  4. Iain M. Cockburn & Megan J. MacGarvie & Elisabeth Müller, 2010. "Patent thickets, licensing and innovative performance," Industrial and Corporate Change, Oxford University Press and the Associazione ICC, vol. 19(3), pages 899-925, June.
  5. Iain M. Cockburn & Matthew J. Slaughter, 2010. "The Global Location of Biopharmaceutical Knowledge Activity: New Findings, New Questions," Innovation Policy and the Economy, University of Chicago Press, vol. 10(1), pages 129-157.

2009

  1. Iain M. Cockburn & Megan J. MacGarvie, 2009. "Patents, Thickets and the Financing of Early‐Stage Firms: Evidence from the Software Industry," Journal of Economics & Management Strategy, Wiley Blackwell, vol. 18(3), pages 729-773, September.

2008

  1. P. D. Chwelos & E. R. Berndt & I. M. Cockburn, 2008. "Faster, smaller, cheaper: an hedonic price analysis of PDAs," Applied Economics, Taylor & Francis Journals, vol. 40(22), pages 2839-2856.

2006

  1. Ernst Berndt & Iain Cockburn & Karen Grépin, 2006. "The Impact of Incremental Innovation in Biopharmaceuticals," PharmacoEconomics, Springer, vol. 24(2), pages 69-86, December.
  2. Henri, Jean-Francois, 2006. "Management control systems and strategy: A resource-based perspective," Accounting, Organizations and Society, Elsevier, vol. 31(6), pages 529-558, August.

2005

  1. Jeffrey Furman & Margaret K. Kyle & Alain Cockburn & Rebecca M. Henderson, 2005. "Public & Private Spillovers: Location and the Productivity of Pharmaceutical Research," Annals of Economics and Statistics, GENES, issue 79-80, pages 165-188.

2003

  1. Agrawal, Ajay & Cockburn, Iain, 2003. "The anchor tenant hypothesis: exploring the role of large, local, R&D-intensive firms in regional innovation systems," International Journal of Industrial Organization, Elsevier, vol. 21(9), pages 1227-1253, November.

2001

  1. Cockburn, Iain M. & Henderson, Rebecca M., 2001. "Scale and scope in drug development: unpacking the advantages of size in pharmaceutical research," Journal of Health Economics, Elsevier, vol. 20(6), pages 1033-1057, November.
  2. Lanjouw, Jean O. & Cockburn, Iain M., 2001. "New Pills for Poor People? Empirical Evidence after GATT," World Development, Elsevier, vol. 29(2), pages 265-289, February.

2000

  1. Iain M. Cockburn & Rebecca M. Henderson & Scott Stern, 2000. "Untangling the origins of competitive advantage," Strategic Management Journal, Wiley Blackwell, vol. 21(10‐11), pages 1123-1145, October.

1998

  1. Wang, Peiming & Cockburn, Iain M & Puterman, Martin L, 1998. "Analysis of Patent Data--A Mixed-Poisson-Regression-Model Approach," Journal of Business & Economic Statistics, American Statistical Association, vol. 16(1), pages 27-41, January.
  2. Iain M. Cockburn & Rebecca M. Henderson, 1998. "Absorptive Capacity, Coauthoring Behavior, and the Organization of Research in Drug Discovery," Journal of Industrial Economics, Wiley Blackwell, vol. 46(2), pages 157-182, June.
  3. Berndt Ernst R. & Cockburn Iain M. & Cocks Douglas L. & Epstein Arnold M. & Griliches Zvi, 1998. "Is Price Inflation Different for the Elderly? An Empirical Analysis of Prescription Drugs," Forum for Health Economics & Policy, De Gruyter, vol. 1(1), pages 1-45, January.

1997

  1. Griliches, Zvi & Cockburn, Iain, 1997. "Generics and New Goods in Pharmaceutical Price Indexes: Reply," American Economic Review, American Economic Association, vol. 87(4), pages 768-768, September.
  2. Sara Ellison Fisher & Iain Cockburn & Zvi Griliches & Jerry Hausman, 1997. "Characteristics of Demand for Pharmaceutical Products: An Examination of Four Cephalosporins," RAND Journal of Economics, The RAND Corporation, vol. 28(3), pages 426-446, Autumn.

1996

  1. Ernst R. Berndt & Iain M. Cockburn & Zvi Griliches, 1996. "Pharmaceutical Innovations and Market Dynamics: Tracking Effects on Price Indexes for Antidepressant Drugs," Brookings Papers on Economic Activity, Economic Studies Program, The Brookings Institution, vol. 27(1996 Micr), pages 133-199.
  2. Rebecca Henderson & Iain Cockburn, 1996. "Scale, Scope, and Spillovers: The Determinants of Research Productivity in Drug Discovery," RAND Journal of Economics, The RAND Corporation, vol. 27(1), pages 32-59, Spring.

1995

  1. Amit, Raphael & Muller, Eitan & Cockburn, Iain, 1995. "Opportunity costs and entrepreneurial activity," Journal of Business Venturing, Elsevier, vol. 10(2), pages 95-106, March.

1994

  1. Griliches, Zvi & Cockburn, Iain, 1994. "Generics and New Goods in Pharmaceutical Price Indexes," American Economic Review, American Economic Association, vol. 84(5), pages 1213-1232, December.
  2. Iain Cockburn & Rebecca Henderson, 1994. "Racing To Invest? The Dynamics of Competition in Ethical Drug Discovery," Journal of Economics & Management Strategy, Wiley Blackwell, vol. 3(3), pages 481-519, September.
  3. Rebecca Henderson & Iain Cockburn, 1994. "Measuring Competence? Exploring Firm Effects in Pharmaceutical Research," Strategic Management Journal, Wiley Blackwell, vol. 15(S1), pages 63-84, December.

1988

  1. Cockburn, Iain & Griliches, Zvi, 1988. "Industry Effects and Appropriability Measures in the Stock Market's Valuation of R&D and Patents," American Economic Review, American Economic Association, vol. 78(2), pages 419-423, May.

Chapters

2018

  1. Iain M. Cockburn & Rebecca Henderson & Scott Stern, 2018. "The Impact of Artificial Intelligence on Innovation: An Exploratory Analysis," NBER Chapters, in: The Economics of Artificial Intelligence: An Agenda, pages 115-146, National Bureau of Economic Research, Inc.

2014

  1. Richard B. Freeman & Ina Ganguli & Raviv Murciano-Goroff, 2014. "Why and Wherefore of Increased Scientific Collaboration," NBER Chapters, in: The Changing Frontier: Rethinking Science and Innovation Policy, pages 17-48, National Bureau of Economic Research, Inc.

2013

  1. Murray L. Aitken & Ernst R. Berndt & Barry Bosworth & Iain M. Cockburn & Richard Frank & Michael Kleinrock & Bradley T. Shapiro, 2013. "The Regulation of Prescription Drug Competition and Market Responses: Patterns in Prices and Sales following Loss of Exclusivity," NBER Chapters, in: Measuring and Modeling Health Care Costs, pages 243-271, National Bureau of Economic Research, Inc.

2011

  1. Iain M. Cockburn & Scott Stern & Jack Zausner, 2011. "Finding the Endless Frontier: Lessons from the Life Sciences Innovation System for Energy R&D," NBER Chapters, in: Accelerating Energy Innovation: Insights from Multiple Sectors, pages 113-157, National Bureau of Economic Research, Inc.
  2. Iain M. Cockburn, 2011. "Comment on "The Confederacy of Heterogeneous Software Organizations and Heterogeneous Developers: Field Experimental Evidence on Sorting and Worker Effort"," NBER Chapters, in: The Rate and Direction of Inventive Activity Revisited, pages 502-505, National Bureau of Economic Research, Inc.

2010

  1. Iain M. Cockburn & Matthew J. Slaughter, 2010. "The Global Location of Biopharmaceutical Knowledge Activity: New Findings, New Questions," NBER Chapters, in: Innovation Policy and the Economy, Volume 10, pages 129-157, National Bureau of Economic Research, Inc.
  2. Ajay Agrawal & Iain Cockburn & Carlos Rosell, 2010. "Not Invented Here? Innovation in Company Towns," NBER Chapters, in: Cities and Entrepreneurship, National Bureau of Economic Research, Inc.
  3. Jeffrey L. Furman & Margaret K. Kyle & Iain Cockburn & Rebecca M. Henderson, 2010. "Public and Private Spillovers: Location and the Productivity of Pharmaceutical Research," NBER Chapters, in: Contributions in Memory of Zvi Griliches, pages 165-188, National Bureau of Economic Research, Inc.

2009

  1. Iain M. Cockburn, 2009. "Comments on Nathan Rosenberg’s ‘Critical Episodes in the Progress of Medical Innovation’," Chapters, in: Dominique Foray (ed.), The New Economics of Technology Policy, chapter 11, Edward Elgar Publishing.

2007

  1. Iain M. Cockburn, 2007. "Is the Pharmaceutical Industry in a Productivity Crisis?," NBER Chapters, in: Innovation Policy and the Economy, Volume 7, pages 1-32, National Bureau of Economic Research, Inc.
  2. Iain M. Cockburn & Megan J. MacGarvie, 2007. "Patents, Thickets and the Financing of Eastly-Stage Firms; Evidence from the Software Industry," NBER Chapters, in: Entrepreneurship: Strategy and Structure, National Bureau of Economic Research, Inc.

2001

  1. Iain M. Cockburn & Rebecca M. Henderson, 2001. "Publicly Funded Science and the Productivity of the Pharmaceutical Industry," NBER Chapters, in: Innovation Policy and the Economy, Volume 1, pages 1-34, National Bureau of Economic Research, Inc.
  2. Iain M. Cockburn & Aslam H. Anis, 2001. "Hedonic Analysis of Arthritis Drugs," NBER Chapters, in: Medical Care Output and Productivity, pages 439-462, National Bureau of Economic Research, Inc.

1998

  1. Ernst R. Berndt & Iain M. Cockburn & Douglas L. Cocks & Arnold M. Epstein & Zvi Griliches, 1998. "Is Price Inflation Different for the Elderly? An Empirical Analysis of Prescription Drugs," NBER Chapters, in: Frontiers in Health Policy Research, Volume 1, pages 33-76, National Bureau of Economic Research, Inc.

IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.